Investigation of Potential Drug Targets Involved in Inflammation Contributing to Alzheimer's Disease Progression
Alzheimer's disease has become a major public health issue. While extensive research has
been conducted in the last few decades, few drugs have been approved by the FDA to treat …
been conducted in the last few decades, few drugs have been approved by the FDA to treat …
Drugs targeting APOE4 that regulate beta‐amyloid aggregation in the brain: therapeutic potential for Alzheimer's disease
J Poblano, I Castillo‐Tobías, L Berlanga… - Basic & Clinical …, 2024 - Wiley Online Library
Alzheimer's disease is characterized by progressive cognitive decline, and behavioural and
psychological symptoms of dementia are common. The APOE ε4 allele, a genetic risk factor …
psychological symptoms of dementia are common. The APOE ε4 allele, a genetic risk factor …
Investigation of potential drug targets for cholesterol regulation to treat Alzheimer's disease
Despite extensive research and seven approved drugs, the complex interplay of genes,
proteins, and pathways in Alzheimer's disease remains a challenge. This implies the …
proteins, and pathways in Alzheimer's disease remains a challenge. This implies the …
[HTML][HTML] Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer's Disease
Alzheimer's disease is a neurodegenerative disease that continues to have a rising number
of cases. While extensive research has been conducted on Alzheimer's disease in the last …
of cases. While extensive research has been conducted on Alzheimer's disease in the last …